LBP-029 Efficacy and safety of 144 weeks of bulevirtide 2 mg or 10 mg monotherapy from the ongoing phase 3 study, MYR301

Saved in:
Bibliographic Details
Published inJournal of hepatology Vol. 80; p. S92
Main Authors Lampertico, Pietro, Aleman, Soo, Brunetto, Maurizia, Blank, Antje, Andreone, Pietro, Bogomolov, Pavel, Chulanov, Vladimir, Mamonova, Nina, Geyvandova, Natalia, Morozov, Viacheslav, Sagalova, Olga, Stepanova, Tatyana, Chee, Grace M., Manuilov, Dmitry, Li, Mingyang, Tseng, Steve, Lau, Audrey, Osinusi, Anu, zur Wiesch, Julian Schulze, Cornberg, Markus, Zeuzem, Stefan, Wedemeyer, Heiner
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.06.2024
Online AccessGet full text

Cover

More Information
ISSN:0168-8278
1600-0641
DOI:10.1016/S0168-8278(24)00596-8